Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-23-012361

Head of Pharm Ops and Tech gave up 116 shares (to pay taxes)

  • Head of Pharm Ops and Tech acquired 239 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Murphy Nicole Head of Pharm Ops and Tech 2023-03-31 Option exercise +239 5,818.29 D: show line 1 in the form
Murphy Nicole Head of Pharm Ops and Tech 2023-03-31 Shares withheld for taxes −116 $278.03 $32,251 5,702.29 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Murphy Nicole Head of Pharm Ops and Tech 2023-03-31 Option exercise · Restricted Stock Unit −239 240 D: show line 3 in the form
Loading xslF345X04/form4.xml…